For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
A neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device intended to retrieve or destroy blood clots in the cerebral neurovasculature.
LPI (LP Information)' newest research report, the "Neurothrombectomy Devices Industry Forecast" looks at past sales and reviews total world Neurothrombectomy Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurothrombectomy Devices sales for 2023 through 2029. With Neurothrombectomy Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurothrombectomy Devices industry.
This Insight Report provides a comprehensive analysis of the global Neurothrombectomy Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurothrombectomy Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neurothrombectomy Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurothrombectomy Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurothrombectomy Devices.
The global Neurothrombectomy Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
In Europe, Neurothrombectomy Devices key players include Stryker, etc. Europe top one manufacturer hold a share over 25%. Germany is the largest market, with a share over 15%.
In terms of product, Retriever is the largest segment, with a share over 90%. And in terms of application, the largest application is Hospitals, followed by Clinics.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurothrombectomy Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Retriever
- Integrated System
Segmentation by application
- Hospitals
- Clinics
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Stryker
- Medtronic
- Penumbra
- Phenox
- Acandis GmbH
Key Questions Addressed in this Report
What is the 10-year outlook for the global Neurothrombectomy Devices market?
What factors are driving Neurothrombectomy Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurothrombectomy Devices market opportunities vary by end market size?
How does Neurothrombectomy Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?